Kiromic stock soars 65% on FDA fast track status for Deltacel

seekingalpha08-15

Kiromic (OTCQB:KRBP) shares soared 65% Wednesday on news the FDA has granted fast track designation to its Gamma Delta T-cell therapy Deltacel, also known as KB-GDT-01, in the treatment of certain ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2459258489?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387472103/image_1387472103.jpg","is_english":true,"pubTime":"2024-08-15 02:50","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2459258489","market":"nz","top_or_hot":-1,"title":"Kiromic stock soars 65% on FDA fast track status for Deltacel","media":"seekingalpha","content":"<div>\n<p>Kiromic (OTCQB:KRBP) shares soared 65% Wednesday on news the FDA has granted fast track designation to its Gamma Delta T-cell therapy Deltacel, also known as KB-GDT-01, in the treatment of certain ...</p>\n\n<a href=\"https://seekingalpha.com/news/4139979-kiromic-stock-soars-on-fda-fast-track-status-for-deltacel\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kiromic stock soars 65% on FDA fast track status for Deltacel</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKiromic stock soars 65% on FDA fast track status for Deltacel\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-15 02:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4139979-kiromic-stock-soars-on-fda-fast-track-status-for-deltacel><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Kiromic (OTCQB:KRBP) shares soared 65% Wednesday on news the FDA has granted fast track designation to its Gamma Delta T-cell therapy Deltacel, also known as KB-GDT-01, in the treatment of certain ...</p>\n\n<a href=\"https://seekingalpha.com/news/4139979-kiromic-stock-soars-on-fda-fast-track-status-for-deltacel\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/4139979-kiromic-stock-soars-on-fda-fast-track-status-for-deltacel","article_id":"2459258489","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387472103/image_1387472103.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2459258489","pubTimestamp":1723661447,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Kiromic  shares soared 65% Wednesday on news the FDA has granted fast track designation to its Gamma Delta T-cell therapy Deltacel, also known as KB-GDT-01, in the treatment of certain lung cancer patients. The FDA granted the designation for KB-GDT-01 in combination with low-dose radiation therapy for the treatment of patients with metastatic non-small cell lung cancer who have progressed on at least two lines of standard of care therapy, including platinum-based chemotherapy, immune checkpoint inhibitors and targeted therapy.  Deltacel is currently in Phase 1 testing for patients with stage 4 non-small cell lung cancer who have failed to respond to standard therapies, according to a statement.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","KRBP":"Kiromic BioPharma, Inc."},"translate_title":"Deltacel获得FDA快速通道地位，Kiromic股价飙升65%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KRBP":1},"content_text":"Kiromic (OTCQB:KRBP) shares soared 65% Wednesday on news the FDA has granted fast track designation to its Gamma Delta T-cell therapy Deltacel, also known as KB-GDT-01, in the treatment of certain lung cancer patients. The FDA granted the designation for KB-GDT-01 in combination with low-dose radiation therapy for the treatment of patients with metastatic non-small cell lung cancer who have progressed on at least two lines of standard of care therapy, including platinum-based chemotherapy, immune checkpoint inhibitors and targeted therapy.  Deltacel is currently in Phase 1 testing for patients with stage 4 non-small cell lung cancer who have failed to respond to standard therapies, according to a statement.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2459258489"}